单细胞转录组学揭示了瘤进化:希望之城临床试验团队的观点
Patrick A Cosgrove1, Andrea H Bild1, Thanh H Dellinger2
1Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.
Journal of clinical medicine
|January 8, 2025
概括
单细胞RNA测序 (scRNA-seq) 揭示了瘤异质性,影响了癌症治疗. 将这项技术整合到临床试验中需要一种协作"团队医学"方法,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 翻译研究是翻译研究.
背景情况:
- 由遗传和表型变异驱动的瘤异质性,显著影响癌症治疗疗效和患者的治疗结果.
- 传统的批量基因组方法缺乏能够捕捉到瘤进化和治疗反应的细胞水平洞察力的分辨率.
研究的目的:
- 探索单细胞RNA测序 (scRNA-seq) 在临床试验中理解瘤异质性的应用.
- 确定挑战,并提出解决方案,将scRNA-seq整合到临床试验设计中.
主要方法:
- 在单个细胞水平上实施scRNA-seq用于转录基因分析.
- 收集研究活检并将其整合到临床试验工作流程中.
- 计算和临床团队之间的协作努力.
主要成果:
- scRNA-seq提供了关于瘤组成,细胞状态和抵抗机制的详细见解.
- 确定了活检采集和scRNA-seq实施的关键技术考虑因素.
- 在乳腺,大脑和卵巢癌试验中整合scRNA-seq的经验教训.
结论:
- 单细胞基因组学,特别是scRNA-seq,对于剖析瘤异质性和告知治疗策略至关重要.
- 合作的"团队医学"方法对于克服临床试验中的实施挑战至关重要.
- 这种方法增强了对瘤微环境和耐药性的理解.
更多相关视频
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


